Dr. Karen Russell, MD
Claim this profileTallahassee Memorial Cancer Center
Studies Breast Cancer
Studies Thyroid Cancer
7 reported clinical trials
18 drugs studied
Area of expertise
1Breast Cancer
Stage I
Stage II
HER2
2Thyroid Cancer
Affiliated Hospitals
Clinical Trials Karen Russell, MD is currently running
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
More about Karen Russell, MD
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Karen Russell, MD has experience with
- Abemaciclib
- Selpercatinib (LOXO-292)
- Liposomal Irinotecan
- Oxaliplatin
- 5-FU
- Additional Support Program Via Text Messaging And Telephone-Based Counseling
Breakdown of trials Karen Russell, MD has run
Breast Cancer
Thyroid Cancer
Papillary Thyroid Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Karen Russell, MD specialize in?
Karen Russell, MD focuses on Breast Cancer and Thyroid Cancer. In particular, much of their work with Breast Cancer has involved Stage I patients, or patients who are Stage II.
Is Karen Russell, MD currently recruiting for clinical trials?
Yes, Karen Russell, MD is currently recruiting for 3 clinical trials in Tallahassee Florida. If you're interested in participating, you should apply.
Are there any treatments that Karen Russell, MD has studied deeply?
Yes, Karen Russell, MD has studied treatments such as Abemaciclib, Selpercatinib (LOXO-292), Liposomal Irinotecan.
What is the best way to schedule an appointment with Karen Russell, MD?
Apply for one of the trials that Karen Russell, MD is conducting.
What is the office address of Karen Russell, MD?
The office of Karen Russell, MD is located at: Tallahassee Memorial Cancer Center, Tallahassee, Florida 32308 United States. This is the address for their practice at the Tallahassee Memorial Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.